Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibodies to cholesterol.

G M Swartz1, M K Gentry, L M Amende

  • 1Department of Membrane Biochemistry, Walter Reed Army Institute of Research, Washington, DC 20307-5100.

Proceedings of the National Academy of Sciences of the United States of America
|March 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suppression of cytotoxicity of diphtheria toxin by monoclonal antibodies against phosphatidylinositol phosphate.

Biophysical journal·2009
Same author

Advances in vaccine delivery: transcutaneous immunisation.

Expert opinion on investigational drugs·2005
Same author

Differential trafficking of the Niemann-Pick C1 and 2 proteins highlights distinct roles in late endocytic lipid trafficking.

Acta paediatrica (Oslo, Norway : 1992). Supplement·2004
Same author

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions.

Annals of oncology : official journal of the European Society for Medical Oncology·2003
Same author

Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies.

Journal of liposome research·2003
Same author

Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions.

International immunopharmacology·2001

Cholesterol can be highly immunogenic, readily generating complement-fixing antibodies. Researchers successfully produced monoclonal IgM antibodies to cholesterol by immunizing mice with cholesterol-rich liposomes and lipid A.

Area of Science:

  • Immunology
  • Biochemistry
  • Cardiovascular Research

Background:

  • Cholesterol's role in atherosclerosis pathogenesis is debated.
  • Cholesterol is generally considered poorly immunogenic.
  • Antibodies to cholesterol conjugates have been previously reported.

Purpose of the Study:

  • To investigate cholesterol's immunogenicity.
  • To generate complement-fixing antibodies to cholesterol.
  • To explore the potential for immune responses against cholesterol.

Main Methods:

  • Immunization of mice with liposomes containing high cholesterol content (71%) and lipid A adjuvant.
  • Selection of hybridoma clones secreting antibodies reactive to high-cholesterol liposomes.
  • Enzyme-linked immunosorbent assay (ELISA) and electron microscopy to confirm antibody binding to crystalline cholesterol.

Related Experiment Videos

Main Results:

  • Successfully obtained monoclonal IgM complement-fixing antibodies to cholesterol.
  • Selected antibodies specifically reacted with high-cholesterol (71%) but not low-cholesterol (43%) liposomes.
  • Demonstrated direct binding of antibodies to crystalline cholesterol using electron microscopy.
  • Achieved rapid antibody induction (3 days) with a high success rate (≥70% hybrid cells secreting antibodies).

Conclusions:

  • Cholesterol can be a highly immunogenic molecule.
  • Complement-fixing antibodies to cholesterol can be readily obtained.
  • This finding has implications for understanding immune responses in cholesterol-related diseases like atherosclerosis.